Dudum Andrew's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Jan 29, 2024
- Accession no.
- 0001773751-24-000006
- Filed
- Jan 29, 2024
- Trade date
- Jan 25-29, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.78M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dudum AndrewCIK 0001837796 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2024 | Class A Common Stock | MOption exerciseAcquired | +127,688 | $2.43 | +$310,281.84 | 179,341 | Direct | |
| Jan 25, 2024 | Class A Common Stock | SSaleDisposed | −127,688 | $9.08F2 | −$1,159,407.04 | 51,653 | Direct | |
| Jan 26, 2024 | Class A Common Stock | MOption exerciseAcquired | +52,940 | $2.43 | +$128,644.2 | 104,593 | Direct | |
| Jan 26, 2024 | Class A Common Stock | SSaleDisposed | −52,940 | $9.11F2 | −$482,283.4 | 51,653 | Direct | |
| Jan 29, 2024 | Class A Common Stock | MOption exerciseAcquired | +15,100 | $2.43 | +$36,693 | 66,753 | Direct | |
| Jan 29, 2024 | Class A Common Stock | SSaleDisposed | −15,100 | $9.01F3 | −$136,051 | 51,653 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2024 | Class A Common Stock | MOption exerciseDisposed | −127,688 | $0.00 | $0 | 2,805,194 | Direct | |
| Jan 26, 2024 | Class A Common Stock | MOption exerciseDisposed | −52,940 | $0.00 | $0 | 2,752,254 | Direct | |
| Jan 29, 2024 | Class A Common Stock | MOption exerciseDisposed | −15,100 | $0.00 | $0 | 2,737,154 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.205. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 2 transactions in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.03. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.